BSAC Spring Conference & AGM
Addressing the AMR burden in everyday practice
18-19 May 2023
QEII Conference Centre London & online
Welcome to the BSAC Spring Conference
Welcome to the BSAC Spring Conference & AGM 2023: Addressing the AMR burden in everyday practice
You can still register below to view the recorded content from this hybrid conference.
If you have already registered, please use the login information you were sent on registration to access the recorded content. For any queries, please contact Esme Carruthers.
This conference is RCPath CPD accredited.
Programme
0830
0930
1400
1030
0330
Registration & coffee
0920
1020
1450
1120
0420
Welcome and opening remarks
Dr David Jenkins, University Hospitals of Leicester NHS Trust & BSAC President - View Bio
SESSION ONE: Emerging, imported and forgotten infections
Chair: Dr David Jenkins, University Hospitals of Leicester NHS Trust & BSAC President - View Bio
0925
1025
1455
1125
0425
Management of imported infections - CPE from Ukranian casualties treated in The Netherlands
Dr Daan Notermans, Medical Microbiologist, Dutch National Institute for Public Health and the Environment (RIVM) - View Bio
0945
1045
1515
1145
0445
Tuberculosis - programmatic testing and treatment for latent tuberculosis in migrants
Professor Ajit Lalvani, NIHR Health Protection Research Unit in Respiratory Infections, Imperial College London - View Bio
1005
1105
1535
1205
0505
Group A streptococcus pleural empyema in children
Dr Thomas Christie Williams, Wellcome Trust ECAT Clinical Lecturer, The University of Edinburgh & Registrar in Respiratory Paediatrics at the Royal Hospital for Children, Glasgow - View Bio
1025
1125
1555
1225
0525
Q&A
1035
1135
1605
1235
0535
BREAK, EXHIBITION & POSTER VIEWING
SESSION TWO: Recording AMR as primary cause or contributory cause of death
Chair: Mr David Aaronovitch, Journalist, The Times
1105
1205
1635
1305
0605
Balancing the opportunity and risk: the political importance of making this happen
Professor Dame Sally Davies, UK Government Special Envoy on Antimicrobial Resistance, UK Department of Health and Social Care - View Bio
1125
1225
1655
1325
0625
Death certification and AMR
Dr Alan Fletcher, National Medical Examiner for England and Wales - View Bio
1145
1245
1715
1345
0645
What education, training and advocacy is now needed?
Dr David Jenkins, University Hospitals of Leicester NHS Trust & BSAC President - View Bio
1205
1305
1735
1405
0705
Panel discussion
SESSION THREE: Invited lectures
Chair: Dr Jacqueline Sneddon, Programmes Manager, BSAC - View Bio
1225
1325
1755
1425
0725
New models of antimicrobial funding in England
Professor Philip Howard OBE, AMR Regional Antimicrobial Stewardship Lead, NHS England & NHS Improvement - North-East & Yorkshire, UK and immediate Past President, BSAC - View Bio
1245
1345
1815
1445
0745
UKAR update
Professor Gareth Jones, Professor in Epidemiology at the University of Aberdeen and Co-Chief Investigator of the UK Antimicrobial Registry - View Bio
1305
1405
1835
1505
0805
Q&A
1315
1415
1845
1515
0815
LUNCH, EXHIBITION & POSTER VIEWING
1320
1420
1850
1520
0820
BSAC AGM
SESSION FOUR
Chair: Dr Luke Moore, Consultant Infectious Diseases, Microbiology, & Virology, Chelsea & Westminster NHS Foundation Trust, Consultant Microbiology, North West London Pathology, Imperial College Healthcare NHS Trust, Honorary Clinical Senior Lecturer, Imperial College London - View Bio
Supported by: Shionogi
1415
1515
1945
1615
0915
Delinkage: A Year in Review
Dr Ioannis Baltas, Internal Medicine Trainee, Northwick Park Hospital - View Bio
SESSION FIVE: Fungal infection challenges
Chair: Professor Philip Howard OBE, AMR Regional Antimicrobial Stewardship Lead, NHS England & NHS Improvement - North-East & Yorkshire, UK and immediate Past President, BSAC - View Bio
1500
1600
2030
1700
1000
Systemic fungal infections - the stewardship challenges
Ms Laura Whitney, Regional Antimicrobial Stewardship Lead London, NHS England and NHS Improvement - View Bio
1520
1620
2050
1720
1020
Implementation of an antifungal stewardship program and the impact on a stem cell transplant centre
Mr Richard Wilson, Research Pharmacist, Imperial College London - View Bio
1540
1640
2110
1740
1040
Candida resistance in the ICU
Dr Tihana Bicanic, Reader & Consultant in Infectious Diseases, St George’s University of London & St George’s Hospital - View Bio
1600
1700
2130
1800
1100
Q&A
SESSION SIX
Chair: Dr Louise Sweeney, Consultant Medical Microbiologist, Manchester University NHS Foundation Trust - View Bio
Supported by: Pfizer
1615
1715
2145
1815
1115
Why we need a new approach: challenging the way we treat MDR Gram-negative infections
Associate Professor Louis Grandjean, Clinical Associate Professor UCL and Honorary Consultant in Paediatric Infectious Diseases Great Ormond Street Hospital & Dr James Hatcher, Consultant Microbiologist Great Ormond Street Hospital.
Date of Prep May 2023 PP-ZVA-GBR-1794
SESSION SEVEN: Keynote Lecture
Chair: Dr Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde - View Bio
1650
1750
2220
1850
1150
Rethinking AMS: New ideas for appropriate access from India
Dr Ramanan Laxminarayan, President of the One Health Trust, Senior Research Scholar, Princeton University - View Bio
1710
1810
2240
1910
1210
Q&A
1720
1820
2250
1920
1220
Day 1 - closing remarks
Dr Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde - View Bio
0730
0830
1300
0930
0230
Registration & coffee
SESSION EIGHT: CLINICAL LESSONS
Chair: Dr Helena Parsons Consultant Microbiologist, Sheffield Teaching Hospitals - View Bio
0800
0900
1330
1000
0300
Understanding the role of accessory genes in AMR phenotype using interpretable machine learning models.
Miss Lucy Dillon, PhD Student, Queen's University Belfast - View Bio
0813
0913
1343
1013
0313
The consumption of human antibiotics in veterinary medicine, in Estonia, 2006–2022
Mrs Marju Sammul, PhD Student, Estonian University of Life Sciences - View Bio
0826
0926
1356
1026
0326
Patterns of general practitioner and nurse independent prescriber prescriptions for antibiotics dispensed in the community in England: A retrospective analysis
Professor Molly Courtenay, Cardiff University - View Bio
0839
0939
1409
1039
0339
Penicillin and cephalosporin cross-reactivity; a single centre UK study
Miss Eve Duke, Pharmacist, Leeds Teaching Hospitals Trust
SESSION NINE: Penicillin allergy de-labelling
Chair: Dr Sanjay Patel, Consultant in Paediatric Infectious Diseases and Immunology, Southampton Children’s Hospital - View Bio
0900
1000
1430
1100
0400
How do we translate policy to practice in the UK
Dr Louise Savic, Leeds Teaching Hospitals - View Bio
0920
1020
1450
1120
0420
Penfast study - lessons from Australia
Associate Professor Jason Trubiano, Infectious Diseases Physician & NHMRC Early Career Researcher, University of Melbourne, Department of Medicine (Austin Health) - View Bio
0940
1040
1510
1140
0440
Q&A
SESSION TEN: Invited lecture
Chair: Professor Tim Walsh, University of Oxford - View Bio
1000
1100
1530
1200
0500
Nothing changes unless it changes: The role of rapid diagnostics in hepatology
Dr Vishal Patel, Consultant Hepatologist, Liver Unit, King's College Hospital London & Principal Investigator, The Roger Williams Institute of Hepatology, Foundation for Liver Research - View Bio
1020
1120
1550
1220
0520
Q&A
1030
1130
1600
1230
0530
REFRESHMENT BREAK, POSTER VIEWING
SESSION ELEVEN
Chair: Dr Beryl Oppenheim, Senior Director, Medical Affairs, Cepheid - View Bio
Supported by: Cepheid
1100
1200
1630
1300
0600
PCR – There’s no CPE control without it
Dr David Jenkins, University Hospitals of Leicester NHS Trust - View Bio
SESSION TWELVE: Sustainability and innovation: Securing the future of antimicrobials
Chair: Dr Aimee Murray, Senior Lecturer, University of Exeter - View Bio
1135
1235
1705
1335
0635
The post treatment impact of antimicrobials in the environment – a threat to yet be understood?
Professor Will Gaze, University of Exeter - View Bio
1155
1255
1725
1355
0655
Achieving sustainable antimicrobial usage: exploring the “how” from a systems perspective
Dr Kelly Thornber, Research Fellow, University of Exeter - View Bio
1215
1315
1745
1415
0715
Confronting a Permacrisis - the intersection between antimicrobial resistance, climate change and biodiversity loss
Mr Tom Tayler, Aviva Investors - View Bio
1235
1335
1805
1435
0735
Q&A
SESSION THIRTEEN
Supported by: Pfizer
1300
1400
1830
1500
0800
Immunity to fungi and therapeutic prospects
Dr Rebecca Drummond, Fungal Immunologist University of Birmingham & Dr Riina Richardson, Senior clinical lecturer in infectious diseases and honorary consultant in medical mycology. Division of Evolution, Infection and Genomics Faculty of Biology, Medicine and Health University of Manchester. Mycology Reference Centre Manchester and Department of Infectious Diseases Manchester University NHS Foundation Trust Wythenshawe Hospital.
Date of Prep May 2023 PP-CRB-GBR-1949
1330
1430
1900
1530
0830
LUNCH, NETWORKING & POSTER VIEWING
SESSION FOURTEEN
Chair: Mr Neil Powell, Consultant Antimicrobial Pharmacist & Associate Director, Antimicrobial Stewardship, Royal Cornwall Hospital Trust - View Bio
Supported by: Thermo Fisher
1410
1510
1940
1610
0910
PCT-aided antibiotic stewardship – new evidence in acute pancreatitis
Professor Ajith Siriwardena, Consultant Hepatobiliary & General Surgeon, Manchester University Hospitals NHS Foundation Trust - View Bio
SESSION FIFTEEN: Alternative approaches and preventative measures
Chair: Dr David Jenkins, University Hospitals of Leicester NHS Trust - View Bio
1445
1545
2015
1645
0945
Phage therapy
Professor Martha Clokie, Professor of Microbiology, University of Leicester - View Bio
1505
1605
2035
1705
1005
Large scale cohort studies and genomics to understand Staphylococcus aureus colonisation and biology
Dr Ewan Harrison, Wellcome Sanger Institute - View Bio
1525
1625
2055
1725
1025
Faecal transplants
Professor Mark Wilcox, Leeds Teaching Hospitals NHS Trust - View Bio
1545
1645
2115
1745
1045
Do it simple, do it well: reducing infection through low cost preventative measures
Professor Tim Walsh, University of Oxford - View Bio
1605
1705
2135
1805
1105
Q&A
SESSION SIXTEEN: Why promoting patient and public advocacy matters to the AMR narrative
Chair: Dr David Jenkins, University Hospitals of Leicester NHS Trust - View Bio
1620
1720
2150
1820
1120
The AMR Narrative
Ms Vanessa Carter, AMR Patient Survivor & One Health Advocate and Founder, The AMR Narrative - View Bio
1645
1745
2215
1845
1145
Q&A
1655
1755
2225
1855
1155
Closing remarks
Dr David Jenkins, University Hospitals of Leicester NHS Trust - View Bio
Registration
Please register to view the recorded content by using the links below. For any questions, please contact Esme Carruthers.
Not a BSAC Member? Membership is FREE! Join here
£160
BSAC Members (NHS/not for profit)
Full conference
£80
BSAC Members (NHS/not for profit)
One day
£200
Non-members (NHS/not for profit)
Full conference
£100
Non-members (NHS/not for profit)
One day
£400
Commercial
Full conference
£200
Commercial
One day
£50
Student & LMIC concessions
Full conference
£25
Student & LMIC concessions
One day
Abstracts
Abstract submission
Submission is now closed
Sponsors
© 2023, British Society for Antimicrobial Chemotherapy. All Rights Reserved.
53 Regent Place, Birmingham B1 3NJ
Registered Charity 1093118